Statistical analysis and decision making in cancer screening.
作者信息
Habbema Dik
机构信息
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
出版信息
Eur J Epidemiol. 2018 May;33(5):433-435. doi: 10.1007/s10654-018-0406-8. Epub 2018 May 12.
Abstract
摘要
相似文献
1
Statistical analysis and decision making in cancer screening.
Eur J Epidemiol. 2018 May;33(5):433-435. doi: 10.1007/s10654-018-0406-8. Epub 2018 May 12.
2
Cancer screening: A modest proposal for prevention.
Cleve Clin J Med. 2019 Mar;86(3):157-160. doi: 10.3949/ccjm.86a.18092.
3
Skin cancer screening and prevention during the COVID-19 pandemic.
Cutis. 2021 Jan;107(1):41-42;53. doi: 10.12788/cutis.0157.
4
From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society.
CA Cancer J Clin. 2018 Jul;68(4):246-249. doi: 10.3322/caac.21459. Epub 2018 May 30.
5
Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening.
Am J Respir Crit Care Med. 2015 Sep 15;192(6):654-6. doi: 10.1164/rccm.201506-1160ED.
6
Screening Refusal Associated with Choice of Colorectal Cancer Screening Methods. A Cross-sectional Study Among Swiss Primary Care Physicians.
J Gen Intern Med. 2019 Aug;34(8):1409-1411. doi: 10.1007/s11606-019-05096-2.
7
Do's and don'ts in evaluation of endoscopic screening for gastrointestinal cancers.
Endoscopy. 2016 Jan;48(1):75-80. doi: 10.1055/s-0034-1393094. Epub 2015 Sep 18.
8
An FP's guide to AI-enabled clinical decision support.
J Fam Pract. 2019 Nov;68(9):486;488;490;492.
9
Currently recommended lung cancer screening guidelines may be insufficient for high-risk minorities.
Cancer. 2019 Jan 1;125(1):10-11. doi: 10.1002/cncr.31898.
10
What Is the Shared Decision-Making Process for Lung Cancer Screening?
ONS Connect. 2016 Feb;31(2):21.
引用本文的文献
1
Dietary Fat and Prostate Cancer Relationship Using Trimmed Regression Under Uncertainty.
Front Nutr. 2022 Mar 10;9:799375. doi: 10.3389/fnut.2022.799375. eCollection 2022.
2
Objectives, design and main findings until 2020 from the Rotterdam Study.
Eur J Epidemiol. 2020 May;35(5):483-517. doi: 10.1007/s10654-020-00640-5. Epub 2020 May 4.
本文引用的文献
1
Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data.
Eur J Epidemiol. 2018 May;33(5):465-472. doi: 10.1007/s10654-017-0339-7. Epub 2017 Dec 5.
2
Models in the development of clinical practice guidelines.
Ann Intern Med. 2014 Dec 2;161(11):812-8. doi: 10.7326/M14-0845.
3
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.
Med Decis Making. 2012 Sep-Oct;32(5):667-77. doi: 10.1177/0272989X12454577.
4
Measuring mortality reductions in cancer screening trials.
Epidemiol Rev. 2011;33:36-45. doi: 10.1093/epirev/mxq021. Epub 2011 May 30.
5
Speaking for the evidence: colonoscopy vs computed tomographic colonography.
J Natl Cancer Inst. 2010 Aug 18;102(16):1212-4. doi: 10.1093/jnci/djq286. Epub 2010 Jul 22.
6
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010.
7
A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.
Cancer. 2009 Jun 1;115(11):2410-9. doi: 10.1002/cncr.24256.
8
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.
Ann Intern Med. 2008 Nov 4;149(9):659-69. doi: 10.7326/0003-4819-149-9-200811040-00244. Epub 2008 Oct 6.
9
Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience.
J Natl Cancer Inst Monogr. 2006(36):122-6. doi: 10.1093/jncimonographs/lgj017.
10
Effect of screening and adjuvant therapy on mortality from breast cancer.
N Engl J Med. 2005 Oct 27;353(17):1784-92. doi: 10.1056/NEJMoa050518.
Zotero 插件